Trial intelligence / Profile preview

Remimazolam and Propofol Combination vs. Propofol for TIVA in Neurosurgery

NCT06382467Phase 4Not yet recruiting

Sponsor
Chung-Ang University Gwangmyeong Hospital
Start
May 2024
Primary completion
May 2025
Modality
Small Molecules
01

Overview

A Phase 4 trial of remimazolam in general anesthesia, sponsored by Chung-Ang University Gwangmyeong Hospital. Planned start May 2024; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT06382467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06382467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call